Virtu KCG Holdings’s Impax Laboratories, Inc. IPXL Stock Holding History

Virtu KCG Holdings’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$231K	Buy	+14,356	New	+$212K	0.01%	2002
2017 Q1	–	Sell	-32,620	Closed	-$432K	–	4090
2016 Q4	$432K	Sell	32,620 -2,841	-8%	-$48.6K	0.01%	1671
2016 Q3	$840K	Buy	35,461 +17,204	+94%	+$462K	0.02%	858
2016 Q2	$526K	Buy	18,257 +5,457	+43%	+$178K	0.01%	1323
2016 Q1	$410K	Buy	+12,800	New	+$450K	0.01%	1397
2015 Q3	–	Sell	-10,753	Closed	-$494K	–	4086
2015 Q2	$494K	Buy	+10,753	New	+$510K	0.01%	1497

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu KCG Holdings's IPXL Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Impax Laboratories, Inc. (IPXL) in Q2 2017: 14,356 shares worth $231K. The stake represents 0.01% of the portfolio and ranks #2002 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in IPXL as recently as Q4 2016.

Virtu KCG Holdings first reported a position in IPXL in Q2 2015 and has held it in 6 quarters since. The position peaked at $840K in Q3 2016. 172 funds tracked by Wall St. Rank hold IPXL as of Q2 2017.

Virtu KCG Holdings held 14,356 shares of Impax Laboratories, Inc. worth $231K as of Q2 2017.
Impax Laboratories, Inc. was a new Virtu KCG Holdings position in Q2 2017.
Impax Laboratories, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2002 holding.
Virtu KCG Holdings first reported a position in Impax Laboratories, Inc. in Q2 2015 and has held it in 6 quarters since.
Virtu KCG Holdings's Impax Laboratories, Inc. position peaked at $840K in Q3 2016.
172 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.